Clinical Trial

GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-05-12; most recent amendment 2024-08-20.
Status change: Not Yet Recruiting → Recruiting 2022-01-21
Trial Details
NCT Number NCT04889794
Lead Sponsor CHU de Quebec-Universite Laval
Collaborators: CISSS de Chaudière-Appalaches, Ciusss de L'Est de l'Île de Montréal, Fonds de la Recherche en Santé du Québec
Conditions Major Neurocognitive Disorder
Enrollment 400 participants
Start Date 2021-09-27
Primary Completion 2025-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-22